About
Surgical device - hemostat, fluid leakage prevention
Areas of Focus
Categories
Surgical DeviceWound HealingBoston & New England
Team (14)
Brock A
Medical Advisor
Arch Therapeutics
advisor
Daniel Kapp, MD
Clinical Advisor, Wound Care and Plastic Surgery
Arch Therapeutics
advisor
Gregory A
Medical Advisor
Arch Therapeutics
advisor
Guy Fish
Director
Arch Therapeutics
team_member
John C. Lantis, MD, FACS
Medical Advisor
Arch Therapeutics
advisor
John Richards, DPhil
Scientific Advisor
Arch Therapeutics
advisor
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
106
By Phase
NA: 2
By Status
UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06028386Lead Sponsor
Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
NAUnknown
60 participants
Started: Aug 15, 2023 · Completed: Aug 30, 2024
NCT02704104Lead Sponsor
Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions
NACompleted
46 participants
Started: Feb 29, 2016 · Completed: Jun 30, 2016
Locations (1)
Headquarters
Framingham, MA, United States
Map
Loading map...